John Maraganore, PhDChief Executive Officer at Alnylam Pharmaceuticals, Inc
John Maraganore, Ph.D., has been the CEO of Alnylam Pharmaceuticals since 2002. Prior to Alnylam, he held positions at Millennium Pharmaceuticals, Biogen (where he co-invented bivalirudin), Zymogenetics, and The Upjohn Company. He received his Ph.D. In biochemistry and molecular biology from the University of Chicago. Dr. Maraganore is the immediate past chair of the Biotechnology Innovation Organization (BIO) and a member of the BIO Executive Committee and is a Director of Agios Pharmaceuticals.